ALSO READSun Pharmaceutical Industries plans to acquire branded oncology product - Odomzo Sun Pharmaceutical Industries receives final approval for generic ezetimibe tablets Sun Pharmaceutical Industries provides business update Sun Pharmaceutical Industries completes acquisition of Ocular Technologies Sun Pharma says 2018 sales may fall as U.S. market gets tougher
Of Rs 3.5 per shareSun Pharmaceuticals Industries announced that the Board of Directors of the Company at its meeting held on 26 May 2017, inter alia, have recommended the final dividend of Rs 3.5 per equity Share (i.e. 350%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)